In vitro antifungal susceptibility profiles of Cryptococcus neoformans and Cryptococcus gattii clinical isolates of in Guangxi, Southern China
ZHENG Dongyan, CAO Cunwei, LI Xiuying, ZHENG Yanqing, PAN Kaisu, LIAO Wangqing
2022, 17(3):
188-194.
Asbtract
(
55 )
PDF (1132KB)
(
18
)
References |
Related Articles |
Metrics
Objective To analyze the clinical characteristics, pathogenic strain identification and in vitro antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii in Guangxi. Methods One hundred and three Cryptococcus strains were isolated from 86 patients with confirmed cryptococcosis (14 were HIV-positive and 72 were HIV-negative) and their clinical characteristics were analyzed. 92 strains were identified as Cryptococcus neoformans grubii variant and 11 strains were identified as Cryptococcus gattii using MALDI-TOF MS and ITS region sequencing molecular identification methods. The strains were tested for in vitro antifungal susceptibility to the commonly used antifungal drugs including fluconazole, amphotericin B, 5-fluorocytosine, itraconazole, voriconazole, posaconazole, and esaconazole referring to the CLSI M27-A4 method. Results There were 59 males and 27 females aged 21-84 years in 86 patients, 55 of them had no underlying disease. Referring to the interpretation criteria in CLSI and EUCAST, all strains were sensitive to most antifungal drugs. The minimum inhibitory concentrations of antifungal drugs against Cryptococcus neoformans var. grubii ranged from 0.05-4 μg/mL for fluconazole, 0.25-1 μg/mL for amphotericin B; 0.0625-2 μg/mL for 5-fluorocytosine, 0.0625-0.25 μg/mL for itraconazole, 0.0078-0.25 μg/mL for voriconazole, 0.0313-0.5 μg/mL for posaconazole, and 0.0020-0.125 μg/mL for estaconazole. The minimum inhibitory concentrations of antifungal drugs against Cryptococcus gattii ranged from 1-16 μg/mL for fluconazole, 0.125-1 μg/mL for 5-fluorocytosine, 0.25-1 μg/mL for amphotericin B, 0.0625-0.25 μg/mL for itraconazole, 0.0156-0.125μg/mL for voriconazole, 0.0156-0.25 μg/mL for posaconazole,and 0.0078-0.125 μg/mL for esaconazole. Conclusion MALDI-TOF MS is a rapid and reliable method for the identification of Cryptococcus. Cryptococci isolated in Guangxi are sensitive to clinical antifungal drugs, and the antifungal sensitivity test helps to detect drug-resistant strains at an early stage, which is important for the effective treatment of cryptococcosis.